Squamous cell carcinoma of the head and neck in the elderly

Reports of Practical Oncology and Radiotherapy

Volumn 18, Issue 1, 2013, Pages 16-25

  Gugić, Jasenka ^a   Strojan, Primož ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Elderly; Geriatric assessment; Head and neck cancer; Radiotherapy; Surgery; Systemic therapy

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL;

CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTINUOUS INFUSION; DIARRHEA; DRUG FATALITY; ELDERLY CARE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LIFE EXPECTANCY; NEPHROTOXICITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTOPENIA;

EID: 84875249910     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.07.014     Document Type: Review

References (92)

1. Sikora A.G., Toniolo P., DeLacure M.D. The changing demographics of head and neck squamous cell carcinoma in the United States. Laryngoscope 2004, 114:1915-1923.
2. SLORA. Ljubljana: Cancer Registry of Republic of Slovenia; 2012. http://www.slora.si/.
3. Muir C.S., Fraumeni J.F., Doll R. The interpretation of time trends. Cancer Surv 1994, 19-20:5-21.
4. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin 1997, 47:5-27.
5. Barzan L., Veronesi A., Caruso G., et al. Head and neck cancer and aging: a retrospective study in 438 patients. J Laryngol Otol 1990, 104:634-640.
6. Sarini J., Fournier C., Lefebvre J.L., Bonafos G., Van J.T., Coche-Dequéant B. Head and neck squamous cell carcinoma in elderly patients. Arch Otolaryngol Head Neck Surg 2001, 127:1089-1092.
7. Vaccher E., Talamini R., Franchin G., Tirelli U., Barzan L. Elderly head and neck (H-N) cancer patients: a monoinstitutional series. Tumori 2002, 88:63-66.
8. Derks W., de Leeuw J.R.J., Hordijk G.J., Winnubst J.A.M. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 2005, 262:21-26.
9. Huang S.H., O'Sullivan B., Waldron J., et al. Patterns of care in elderly head and neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys 2011, 79:46-51.
10. Kennedy B.J. Aging and cancer. J Clin Oncol 1988, 6(12):1903-1911.
11. Brunello A., Sandri R., Extermann M. Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. Cancer Treat Rev 2009, 35:487-492.
12. Paleri V., Wight R.G., Silver C.E., et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol 2010, 46:712-719.
13. Sanabria A., Carvalho A.L., Vartanian J.G., Magrin J., Ikeda M.K., Kowalski L.P. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007, 14:1449-1457.
14. Peters T.T.A., van der Laan B.F.A.M., Plaat B.E.C., Wedman J., Langendijk J.A., Halmos G.B. The impact o comorbidity on treatment-related side effects in older patients with laryngeal cancer. Oral Oncol 2011, 42:56-61.
15. Gosney M.A. Clinical assessment of elderly people with cancer. Lancet Oncol 2005, 6:790-797.
16. Repetto L., Granetto C., Venturino A. Comorbidity and cancer in the aged: the oncologists point of view. Rays 1997, 22:17-19.
17. Chaibi P., Magne N., Breton S., et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011, 79:302-307.
18. Girre V., Falcou M.C., Gisselbrecht M., et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?. J Gerontol A Biol Sci Med Sci 2008, 63:724-730.
19. Massa E., Madeddu C., Astara G., et al. An attempt to correlate a " Multidimensional Geriatric Assessment" (MGC), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study. Crit Rev Oncol Hematol 2008, 66:75-83.
20. Hurria A., Browner I.S., Cohen H.J., et al. NCCN guidelines - senior adult oncology. J Natl Compr Canc Netw 2012, 10:162-209.
21. Milet P.R., Mallet Y., El Bedoui S., Penel N., Servent V., Lefebvre J.L. Head and neck cancer surgery in the elderly - does age influence the postoperative course?. Oral Oncol 2010, 46:92-95.
22. Carvalho A.L., Singh B., Spiro R.H., Kowalski L.P., Shah J.P. Cancer of the oral cavity: a comparison between institutions in a developing and developed nation. Head Neck 2004, 26:31-38.
23. Anantharaman D., Marron M., Lagiou P., et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011, 47:725-731.
24. Koch W.M., Patel H., Brennan J., Boyle J.O., Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 1995, 121:262-265.
25. Ortholan C., Lusinchi A., Italiano A., et al. Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more. Radiother Oncol 2009, 93:516-523.
26. Krouse A.L., Bredell M., Lubbers H.T., Grätz K.W. Head and neck cancer in the elderly: a retrospective study over 10 years (1999-2008). Head Neck Oncol 2010, 2:25.
27. Pignon T., Rafaramino F., Scalliet P. Cancer and the elderly. Management decision aspects. Rev Med Interne 2000, 21:765-776.
28. Campisi J. Proliferative senescence and cancer. Comprehensive geriatric oncology 2004, 127-137. Taylor & Francis, Oxon. 2nd ed. L. Ballduci, G.H. Lyman, W.B. Ershler, M. Extermann (Eds.).
29. Ang K.K., Sturgis E.M. Human papilloma virus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012, 22:128-142.
30. Italiano A., Ortholan C., Dassonville O., et al. Head and neck squamous cell carcinoma in patients aged ≥80 years: patterns of care and survival. Cancer 2008, 113:3160-3168.
31. Pignon T., Horiot J.C., Van den Bogaert W., Van Glabbeke M., Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996, 32A:2075-2081.
32. Bourk M., Chernobilsky B., Rosenfeld R.M., Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 2005, 131:605-609.
33. van der Schroeff M.P., Derks W., Hordijk G.J., de Leeuw R.J. The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study. Eur Arch Otorhinolaryngol 2007, 264:415-422.
34. Airoldi M., Cortesina G., Giordano C., et al. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004, 130:161-166.
35. Patel S., Wolff P.B., Lin B., Karnad A.B. Concurrent chemotherapy plus radiation therapy (CRT) in elderly patients: a retrospective analysis. J Clin Oncol 2010, 28S. [abstract e19660].
36. McGuirt W.F., Loevy S., McCabe B.F., Krause C.J. The risks of major head and neck surgery in the aged population. Laryngoscope 1977, 87:1378-1382.
37. Morgan R.F., Hirata R.M., Jaques D.A., Hoopes J.E. Head and neck surgery in the aged. Am J Surg 1992, 144:449-451.
38. Clayman G.L., Eicher S.A., Sicard M.W., Razmpa E., Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 1998, 20:216-223.
39. Zabrodsky M., Calabrese L., Tosoni A., et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 2004, 13:249-255.
40. Shestak K.C., Jones N.F., Wu W., Johnson J.T., Myers E.N. Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects. Head Neck 1992, 14:14-18.
41. Singh B., Cordeiro P.G., Santamaria E., Shaha A.R., Pfister D.G., Shah J.P. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999, 103:403-411.
42. Beausang E.S., Ang E.E., Lipa J.E., et al. Microvascular free tissue transfer in elderly patients: the Toronto experience. Head Neck 2003, 25:549-553.
43. Coskunfirat O.K., Chen H.C., Spanio S., Tang Y.B. The safety of microvascular free tissue transfer in the elderly population. Plast Reconstr Surg 2005, 1153:771-775.
44. Howard M.A., Cordeiro P.G., Disa J., et al. Free tissue transfer in the elderly: incidence of perioperative complications following microsurgical reconstruction of 197 septuagenarians and octogenarians. Plast Reconstr Surg 2005, 116:1659-1668.
45. Tsai CH, Chang KP, Hung SY, Chen WF, Cheng MH, Kao HK. Postoperative morbidity in head and neck cancer ablative surgery followed by microsurgical free tissue transfer in the elderly. Oral Oncol, in press.
46. Sanabria A., Carvalho A.L., Melo R.L., et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008, 30:170-177.
47. Rudat V., Dietz A., Conradt C., Weber K.J., Flentje M. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 1997, 43:181-188.
48. Lusinchi A., Bourhis J., Wibault P., Le Ridant A.M., Eschwege F. Radiation therapy for head and neck cancer in the elderly. Int J Radiat Oncol Biol Phys 1990, 18:819-823.
49. Huguenin P., Sauer M., Glanzmann C., Lütolf U.M. Radiotherapy for carcinoma of the head and neck in elderly patients. Strahlenther Onkol 1996, 172:485-488.
50. Schofield C.P., Sykes A.J., Slevin N.J., Rashid N.Z.Z. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 2003, 69:37-42.
51. Allal A.S., Maire D., Becker M., Dulguerov P. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 2000, 88:648-652.
52. Zachariah B., Balducci L., Venkattaramanabalaji G.V., Casey L., Greenberg H.M., DelRegato J.A. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997, 39:1125-1129.
53. Oguchi M., Ikeda H., Watanabe T., et al. Experience of 23 patients > or = 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998, 41:407-413.
54. Mitsuhashi N., Hayakawa K., Sakurai H., et al. Cancer in patients aged 90 years or older: radiation therapy. Radiology 1999, 211:829-833.
55. Wasil T., Lichtman S.M., Gupta V., Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000, 23:526-530.
56. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-854.
57. Joseph B., Supe S., Ramachandra A. Cyberknife: a double edge of sword. Rep Pract Oncol Radiother 2010, 15:93-97.
58. Guedea F. Recent development in brachytherapy. Rep Pract Oncol Radiother 2011, 16:203-206.
59. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
60. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010, 28:2732-2738.
61. Mohanti B.K., Umapathy H., Bahadur S., Thakar A., Pathy S. Short course palliative radiotherapy of 20Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 2004, 71:275-280.
62. Corry J., Peters L.J., Costa I.D., et al. The 'QUAD SHOT': a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005, 77:137-142.
63. Porceddu S.V., Rosser B., Burmeister B.H., et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment: " Hypo Trial" Radiother Oncol 2007, 85:456-462.
64. Al-mamgani A., Tans L., Van Rooij P.H., Noever I., Baatenburg de jong R.J., Levendag P.C. Hypofractionated radiotherapy denoted as the " Christie scheme" : an effective means of palliating patients with head and neck cancers not suitable for curative treatment. Acta Oncol 2009, 48:562-570.
65. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350:1945-1952.
66. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007, 357(17):1695-1704.
67. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007, 357:1705-1715.
68. Bourhis J., Sire C., Graff P., et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 2012, 13:145-153.
69. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
70. Pignon J.P., le Maitre A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17346 patients. Radiother Oncol 2009, 92:4-14. on behalf of the MACH-NC Collaborative Group.
71. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008, 26:3582-3589.
72. Argiris A., Li Y., Murphy B.A., Langer C.J., Forastiere A.A. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 2004, 22(2):262-268.
73. Repetto L. Greater risk of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 2003, 1:18-24.
74. Schnider M., Thyss A., Ayela P., Gaspard M.H., Otto J., Creisson A. Chemotherapy for patients aged over 80. Cancer in the elderly 1994, 53-60. Oxford University Press, New York. I.S. Fentiman, S. Monfardini (Eds.).
75. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
76. Vermorken J.B., Mesia R., Rivera F., et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008, 359:1116-1127.
77. Giro C., Berger B., Bölke E., et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother Oncol 2009, 90:166-171.
78. Pryor D.I., Porceddu S.V., Burmeister B.H., et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 2009, 90:172-176.
79. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010, 11:21-28.
80. Jensen A.D., Bergmann Z.P., Garcia-Huttenlocher H., Freier K., Debus J., Münter M.W. Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience. Head Neck Oncol 2010, 2:34.
81. Alongi F., Bignardi M., Garassino I., et al. Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. Strahlenther Onkol 2012, 188:49-55.
82. Quaglia A., Tavilla A., Shack L., et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009, 45:1006-1016.
83. Colonna M., Bossard N., Remontet L., Grosclaude P., FRANCIM Network Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers. Int J Cancer 2011, 127(4):924-931.
84. Bhattacharyya N. A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly. Laryngoscope 2003, 113:368-372.
85. Derks W., de Leeuw R., Winnubst J., Hordijk G.J. Elderly patients with head and neck cancer: physical, social and psychological aspect after 1 year. Acta Otolaryngol 2004, 124:509-514.
86. Derks W., de Leeuw R.J., Hordijk G.J., Winnubst J.A. Quality of life in elderly patients with head and neck cancer only one year after diagnosis. Head Neck 2004, 26:1045-1052.
87. Silveira A.P., Gonçalves J., Sequeira T., et al. Geriatric oncology: comparing health related quality of life in head and neck cancer patients. Head Neck Oncol 2011, 3:3.
88. Laraway DC, Lakshmiah R, Lowe D, Roe B, Rogers SN. Quality of life in older people with oral cancer. Br J Oral Maxillofac Surg, in press.
89. Khafif A., Posen J., Yagil Y., et al. Quality of life in patients older than 75 years following major head and neck surgery. Head Neck 2007, 29:932-939.
90. Rogers S.N., Miller R.D., Ali K., Minhas A.B., Williams H.F., Lowe D. Patients' perceived health status following primary surgery for oral and oropharyngeal cancer. Int J Maxillofac Surg 2006, 35:913-919.
91. Derks W., Leeuw J.R., Hordijk G.J., Winnubst J.A. Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clin Otolaryngol 2005, 30:186-192.
92. Huang T.L., Tsai W.L., Chien C.Y., Lee T.F., Fang F.M. Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy. Qual Life Res 2010, 19:1243-1254.